Zika Virus Testing Market
Market Insights on Zika Virus Testing covering sales outlook, demand forecast & up-to-date key trends
Zika Virus Testing Market by Test Type (Rapid IgG/IgM Test, ELISA Test), End-User (Hospitals & Clinics, Private Commercial Laboratories, Government/Publicly Funded Programs) & Region - Forecast to 2021-2031
About the Report
Diagnostic testing has entered a new phase with the advent of constant viral pandemic and epidemic outbreaks, prompting clinicians and healthcare stakeholders to introduce highly sophisticated and precise testing solutions to ward of such threats. The ever exploding frequencies of viral epidemics has put the global healthcare fraternity at the cusp of significant technological revolutions, which has boded well for the zika virus testing market.
Healthcare providers are increasing leaning towards enzyme-linked immunosorbent (ELISA) and IgG/IgA testing mechanisms, attributed to their high throughput rates and enhanced accuracy degree. Prominent zika virus testing players are also looking to leverage major institutional level collaborations with government agencies as well as private laboratories to accelerate their research and development prospects.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for zika virus treatment. The report tracks the global sales of zika virus treatment in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the healthcare industry in general, and zika virus treatment in particular.
Let us know your requirement to get
100% FREE customization
How do the Historical Projections and Future Outlook Compare?
According to Future Market Insights, the zika virus testing market experienced moderate growth, registering a CAGR of over 2% until 2020. The market surpassed US$ 4 billion in value as government initiatives to contain the virus’s spread resulted in massive awareness campaigns which accelerated the frequency of infection diagnostics and testing.
As the intensity of the epidemic has waned, the incidence of testing has significantly dwindled. However, government and institutional level efforts are unceasing in terms of discovering possible new breakthroughs in the future. Furthermore, the existing COVID-19 pandemic has prompted individuals to screen for any possibility of viral strain presence as a precautionary measure, elevating growth prospects.
How are Increasing Epidemic Outbreaks contributing to Market Growth?
Since the dawn of the 21st century, the global healthcare community has been wrestling with countless epidemic outbreaks, which has significantly stretched existing infrastructure capabilities. Amongst all the pandemics and epidemics faced today, viral infections have acquired the topmost position, with diseases such as the Severe Acute Respiratory Syndrome (SARS), the Middle Eastern Respiratory Syndrome (MERS), Chikungunya, Swine Flu, Zika Virus and the COVID-19 pandemic being some examples.
Fortunately, numerous technological advancements has enabled the global healthcare industry to develop effective virology diagnostic and treatment procedures, leading to the introduction of highly advanced testing mechanisms. Multiple approaches, including viral culture, antigen detection, nucleic acid detection and serology. Viral isolation and a number of methods of detection of viral antigens, nucleic acids, and antibodies are at the core repertoire of techniques used for laboratory diagnosis of numerous viral infections.
All the aforementioned approaches have been extensively deployed to diagnose and contain the zika virus epidemic with largely successful results. Prominent laboratories are investing their funds in developing immunoglobulin testing and enzyme-linked immunosorbent assay (ELISA). Players such as LabCorp are at the forefront of the zika virus testing market, offering the Aptima® Zika Virus Assay and the ZIKV DetectTM IgM Capture ELISA which were authorized for emergency use initially. Such developments are further widening growth prospects in the future.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhy is Demand for Zika Virus Testing High for Pregnant Women?
Documented findings have established that the zika virus has a high possibility of being passed on from a pregnant woman to her fetus. Infection during pregnancy leads to microcephaly and other severe fetal brain defects. Additionally, it may result in neurodevelopmental abnormalities such as hearing and visual impairment, limited locomotion, seizures and other abnormalities.
Therefore, it has become imperative for women to undergo periodic screening for possible presence of the virus in their bloodstream. According to the World Health Organization, zika virus infection is also a trigger for Guillain-Barre syndrome, neuropathy and myelitis, particularly in adults and older children. Hence, it is highly advisable for women residing within zika intensive areas to undergo laboratory testing and other clinical care.
At the same time, clinicians are advocating a slew of preventive measures owing to the dearth of any vaccine or drug to treat the virus. As it is a vector borne disease, mostly through mosquitos, personal protection measures such as wearing light-colored clothing that covers as much of the body as possible. Furthermore, using physical barriers such as window screens and closed doors and windows and applying insect repellants are considered the best alternatives.
Key Challenges faced by the Zika Virus Testing Providers
A major factor impeding revenue growth of the zika virus testing market is the inefficiency of these tests in delivering results. While ELISA tests are said to provide relatively accurate results compared to IgG/IgM testing, yet companies are unable to deliver products owing to cross reactivity with other widely circulating virus strands such as Flavivirus, Dengue, Chikungunya and Japanese Encephalitis.
Furthermore, the outreach of zika virus testing is restricted to tropical regions, as these are the primary infection hotspots, thus restricting their growth scope. Fortunately, countries across the temperate regions are increasing uptake of various serological tests amid growing concerns of the epidemic’s spread by virtue of people frequenting tropical regions for tourism.

An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Analysis
What Prospects are in Store for the US Zika Virus Testing Market?
Presently, as of 2021, there have been no documented instances of local zika virus transmission across the US. However, overseas territories have registered 7 active cases through presumed local mosquito-borne transmission. This number represents an impressive reduction as compared to 2019 levels wherein 28 active cases were reported, 27 in travelers returning from affected areas and 1 from laboratory exposure.
This reduction in cases is majorly credited to numerous regulatory approaches to facilitate active viral case load testing since the past few years. For instance, in May 2019, the Food & Drug Administration authorized marketing of the ZIKV Detect 2.0 IgM Capture ELISA to detect Zika virus Immunoglobulin (IgM) antibodies in human blood. This was the first diagnostic test permitted by the FDA to be commercially available.
Likewise, in July 2019, FDA cleared the ADVIA Center Zika test, making it the second major IgM antibody test to be commercially available. Earlier, this test was only permitted for emergency use by decree of the FDA’s emergency use authorization directive. Two other tests- the LIASION XL Zika Capture IgM Assay II and DPP Zika IgM Assay System were eventually granted approval subsequently. Attributed to these approvals, scope for the US market is increasing manifold.
Is Brazil Expected to Generate Revenue Streams for Prominent Players?
Prominent zika virus testing players are expected to find credible opportunities across the Brazilian market, given the fact it was the epicenter of the initial epidemic outbreak. The outbreak was first documented by the discovery of fetal microcephaly across northeastern Brazil in 2015. In view of the harmful consequence of microcephaly, in November 2015 the Ministry of Health declared a Public Health Emergency of National Concern.
To combat this menace, the Brazilian government introduced a massive nationwide operation to eliminate potential mosquito breeding sites and to educate the public about its role in combating spread of the disease. In the initial stages, health worker or members of the armed forces visited over 20 million homes, representing almost 30% of all the country’s private residences. Such unceasing efforts led to a nationwide improvement in the eradication efforts of the virus.
Presently, Brazilian authorities have taken crucial measures in a transparent and timely manner in line with the International Health Regulations, a legal instrument which is binding for all World Health Organization member states, for which the country has invested in purchasing essential materials such as laboratory reagents, insecticides and diagnostic kits. Moreover, the WHO is also assisting Brazil in strengthening integrated management of disease-carrying organisms in public health, including upscaling use of larvicides to inhibit breeding of the Aedes mosquitos, the main vectors responsible for the virus’ transmission.
How did Puerto Rico Generate High Ground for Zika Virus Testing?
According to the Centers for Disease Control and Prevention (CDC), zika virus is a major factor for microcephaly and other severe birth defects in babies born to women infected with the virus. Women living in Puerto Rico are especially at high risk of zika virus exposure due to local mosquito-borne transmission.
Beginning in 2016, healthcare providers in Puerto Rico were under administrative orders to provide counseling on zika virus risk-reduction strategies, assess patients for possible zika virus exposure during prenatal care visits and conduct prenatal testing for Zika virus. Additionally, the Puerto Rico Department of Health (PRDH) and the CDC worked together to conduct a population-based survey of women who gave birth to a live infant from August to December 2016.
The Pregnancy Risk Assessment Monitoring System - Zika Postpartum Emergency Response (PRAMS-ZPER) survey asked mothers about their use of recommended measures to prevent zika virus infection and their interactions with healthcare providers during their pregnancy. Most respondents replied that they received prenatal care in the 1st trimester (91%), while more than seven out of ten considered their healthcare provider to be the best source of information about the virus. Hence, regular diagnostic tests are administered to them to periodically check for any infections.
What are the Major Zika Virus Testing Guidelines in the UK?
According to Public Health England (PHE), testing for zika virus is available only through the Rare and Imported Pathogens Laboratory (RIPL) at PHE Porton. RIPL provides medical and laboratory specialist services to the National Health Service and other healthcare providers, covering advice and diagnosis of a wide range of unusual bacterial and viral infections, including zika virus infection.
As per UK law, zika virus infection is not a notifiable disease. Therefore, there is no statutory requirement to test for this infection if the result are expected to have a negligible impact on clinical management. Presently, testing services are inaccessible for asymptomatic individuals, including pregnant women, male travelers and couples who are attempting to conceive. Couples planning conception should be strongly advised to follow PHE guidance and delay conception for 3 months after return from a country or area with risk for zika, rather than pay for private zika tests that may not be fully validated for testing people who don’t have symptoms.
With regard to investigating patients with previously suspected infection cases, clinicians can undertake testing for any patient who has had a rash illness or other symptoms suggestive of zika virus infection within 2 weeks of leaving any country suspected of having an outbreak. In such a case, patients have to submit serum or urine samples with an appropriate request form. Additionally, semen samples may also be tested in case of conceiving parents.
Category-wise Insights
Why are ELISA based Tests Most Preferred?
By test type, ELISA-based zika virus testing is the most preferred, surpassing US$ 4 billion until 2020. ELISA tests are highly relied upon due to its high specificity and sensitivity. Additionally, they offer greater accuracy compared to other techniques such as radioimmunoassay (RIA) tests. Moreover, it does not require radioisotopes or costly radiation counters.
Simultaneously, demand for IgG/IgM testing is anticipated to remain equally strong, reaching US$ 26 million in valuation as of 2020. These tests have exhibited promising results due to minimal sample requirement and complications associated with their usage. These tests help in simultaneous detection and differentiation of the zika virus in human serum and plasma.
Demand for Testing Kits to Remain High across Commercial Laboratories?
By end-user, zika virus testing is likely to be extensively carried out by private commercial laboratories. Private laboratories often have more resources at their disposal, including finances for initiating new clinical trials, affordability of sophisticated lab equipment, and enhanced specimen storage capacities among other benefits. Prominent private commercial laboratories offering zika virus testing include Labcorp and ARUP Laboratories among others.
At the same time, government/publicly funded testing programs have experienced a significant incline. For example, in 2016, the US Congress allocated US$ 1.1 billion in supplemental funding to combat the zika virus to the Department of Health and Human Services (HHS), out of which US$ 394 million was allocated to CDC, US$ 152 million to NIH and US$ 387 million towards the public health and emergency fund.
Competitive Landscape
Prominent zika virus testing players are majorly emphasizing on incorporating advanced testing approaches to provide faster turn-around times and quicker results. This helps clinicians suggest the appropriate treatment approach to infected patients. They also rely on strategic collaborations with various institutions and companies to widen their market presence.
EUROIMMUN US is a prominent zika virus test provider, offering the anti-zika virus ELISA and indirect immunofluorescence test (IFA) formats which allows for detection of specific antibodies (IgM and IgG) in the blood of those who may be infected. In 2017, the company entered an optional agreement with Roche Diagnostics in which the latter gained access to intellectual property in zika virus immunodiagnostics assigned to EUROIMMUN.
Similarly, Creative Diagnostics offers the Recombinant Zika Virus Envelope protein test which contains Histidine tags. The protein reacts with both IgG and IgM to provide the desired result. Its purity score ranks above 85%, available in 1 mg vials. It also offers the Recombinant Zika Virus NS1 protein test.
Recently, in April 2021, Luminex Corporation has signed and acquisition agreement with DiaSorin S.p.A. wherein the latter has agreed to acquire the former. Luminex believes that this transaction will generate significant opportunities for both companies to gain access to broader assay portfolios, enhanced research tools and expanded support services. This collaboration will also drive new partnerships in the biopharmaceutical, academic and clinical spaces.
As per FMI’s analysis, the following players operate within the global zika virus testing market:
- EUROIMMUN US Inc.
- Creative Diagnostics
- Quest Diagnostics
- Artron Laboratories Inc.
- RapiGEN Inc.
- GenBody Inc.
- JAJ International Inc.
- LumiQuick Diagnostics Inc.
- Biocan Diagnostics Inc.
- NECTAR LIFESCIENCES LTD.
- Luminex Corporation
- ARUP Laboratories
- Abbott Molecular Inc.
- Hologic
- Vela Diagnostics
*This list is indicative - full details about prominent zika virus testing manufacturers is available upon request
Zika Virus Testing Market - Report Scope
Attribute |
Details |
Forecast Period |
2021-2031 |
Historical Data Available for |
2016-2020 |
Market Analysis |
US$ Mn for Value & ‘000 Units for Volume |
Key Regions Covered |
North America & Europe, Latin America, Central America, Caribbean, South East Asia and Rest of the World |
Key Countries Covered |
US, Brazil, Mexico, Colombia, Germany, Italy, France, UK, Spain, Costa Rica, Nicaragua, Guatemala, Puerto Rico, Thailand, Vietnam, Singapore, North Africa and South Africa |
Key Segments Covered |
Test Type and End-User |
Key Companies Profiled |
|
Report Coverage |
Market Introduction, Market Viewpoint, Market Background, Key Macroeconomic Assumptions, Global Economic Outlook, Key Inclusions, Market Analysis & Forecast, Segmental Analysis, Regional Profiling, Forecast Assumptions, Market Structure Analysis and Competition Analysis |
Customization & Pricing |
Key Segments Covered
Test Type
- Rapid IgG/IgM Test
- ELISA Test
End-User
- Hospitals & Clinics
- Private Commercial Laboratories
- Government/Publicly Funded Programs
Region
- North America & Europe (US, UK, Germany, Spain, France, Italy and Rest of Europe)
- Latin America (Brazil, Mexico, Colombia and Rest of LATAM)
- Central America (Costa Rica, Nicaragua, Guatemala and Rest of Central America)
- Caribbean (Puerto Rico and Rest of the Caribbean)
- South East Asia (Thailand, Singapore, Vietnam and Rest of South East Asia)
- Rest of the World (North Africa and South Africa)
Frequently Asked Questions
The global zika virus testing market is set to register credible gains through 2021 and beyond, registering a multi-billion dollar valuation amid extensive research and development to incorporate highly advanced diagnostic approaches which will help in timely detection and diagnosis of the virus
As per FMI’s report, bulk of all zika virus testing is expected to occur across the tropical regions of the world, such as the Asian sub-continent, Caribbean and Central America respectively
ELISA based zika virus testing treatment will likely remain the most preferred approach in forthcoming years due to its immense promises in terms of higher accuracy and efficacy
EUROIMMUN US Inc., Creative Diagnostics, Quest Diagnostics, Artron Laboratories Inc., RapiGEN Inc., GenBody Inc., JAJ International Inc., LumiQuick Diagnostics Inc., Biocan Diagnostics Inc., NECTAR LIFESCIENCES LTD., Luminex Corporation, ARUP Laboratories, Abbott Molecular Inc., Hologic and Vela Diagnostics are some prominent regenerative medicine players profiled by FMI’s report
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Zika Virus Testing Market View Point
3.1. Tracking the market scenario, with key inferences drawn from historical data, current trends, and future prospects
3.2. Macro-Economic Factors
3.3. Opportunity Analysis
4. Market Background
4.1. Technology Evolution
4.2. List of Growth Hacking Manufacturers
4.3. Value Chain
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity Analysis
4.5. Reimbursement Landscape
4.6. Regulatory Scenario
5. Macroeconomic Assumptions
6. Global Economic Outlook
6.1. Gross Domestic Product by Region & Country, 2021 – 2031
6.2. Disease Outlook
7. Key Inclusions
7.1. Key Distributor List
7.2. Key Mergers & Acquisitions
8. Global Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031 By Region
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2016 – 2020
8.2.1. North America
8.2.2. Latin America
8.2.3. Central America
8.2.4. Caribbean
8.2.5. South East Asia
8.2.6. Rest of the World
8.3. Market Size (US$ Mn) Forecast By Region, 2021 – 2031
8.4. Market Attractiveness Analysis By Region
9. Global Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By End User
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By End User, 2016 – 2020
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies and Drug Stores
9.2.3. Online Sales
9.2.4. Other
9.3. Market Size (US$ Mn) and Volume Forecast By End User, 2021 – 2031
9.4. Market Attractiveness Analysis By End User
10. Global Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
10.1. Market Value Share Analysis, By All Segment
10.2. Y-o-Y Growth Analysis, By All Segment
10.3. Absolute $ Opportunity
11. North America Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
11.1. Introduction
11.2. Key Takeaways
11.3. Regional Market Trends
11.4. U.S. Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
11.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
11.4.1.1. Hospitals & Clinics
11.4.1.2. Private Commercial Laboratories
11.4.1.3. Government/ Publicly Funded Programs
11.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
11.4.3. Pricing Analysis
11.4.4. Government Initiatives and Spending Scenario
11.4.5. Key Competition Mapping
11.5. Market Attractiveness Analysis
11.5.1. By End User
11.6. Key Market Participants – Intensity Mapping
12. Europe Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
12.1. Introduction
12.2. Key Takeaways
12.3. Regional Market Trends
12.4. Germany Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
12.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
12.4.1.1. Hospitals & Clinics
12.4.1.2. Private Commercial Laboratories
12.4.1.3. Government/ Publicly Funded Programs
12.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
12.4.3. Pricing Analysis
12.4.4. Government Initiatives and Spending Scenario
12.4.5. Key Competition Mapping
12.5. United Kingdom Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
12.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
12.5.1.1. Hospitals & Clinics
12.5.1.2. Private Commercial Laboratories
12.5.1.3. Government/ Publicly Funded Programs
12.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
12.5.3. Pricing Analysis
12.5.4. Government Initiatives and Spending Scenario
12.5.5. Key Competition Mapping
12.6. France Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
12.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
12.6.1.1. Hospitals & Clinics
12.6.1.2. Private Commercial Laboratories
12.6.1.3. Government/ Publicly Funded Programs
12.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
12.6.3. Pricing Analysis
12.6.4. Government Initiatives and Spending Scenario
12.6.5. Key Competition Mapping
12.7. Italy Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
12.7.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
12.7.1.1. Hospitals & Clinics
12.7.1.1. Private Commercial Laboratories
12.7.1.1. Government/ Publicly Funded Programs
12.7.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
12.7.3. Pricing Analysis
12.7.4. Government Initiatives and Spending Scenario
12.7.5. Key Competition Mapping
12.8. Spain Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
12.8.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
12.8.1.1. Hospitals & Clinics
12.8.1.2. Private Commercial Laboratories
12.8.1.3. Government/ Publicly Funded Programs
12.8.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
12.8.3. Pricing Analysis
12.8.4. Government Initiatives and Spending Scenario
12.8.5. Key Competition Mapping
12.9. Market Attractiveness Analysis
12.9.1. By Country
12.9.2. By End User
12.10. Key Market Participants – Intensity Mapping
13. Caribbean Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
13.1. Introduction
13.2. Key Takeaways
13.3. Regional Market Trends
13.4. Puerto Rico Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
13.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
13.4.1.1. Hospitals & Clinics
13.4.1.2. Private Commercial Laboratories
13.4.1.3. Government/ Publicly Funded Programs
13.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
13.4.3. Pricing Analysis
13.4.4. Government Initiatives and Spending Scenario
14. Latin America Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
14.1. Introduction
14.2. Key Takeaways
14.3. Regional Market Trends
14.4. Brazil Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
14.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
14.4.1.1. Hospitals & Clinics
14.4.1.2. Private Commercial Laboratories
14.4.1.3. Government/ Publicly Funded Programs
14.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
14.4.3. Pricing Analysis
14.4.4. Government Initiatives and Spending Scenario
14.5. Mexico Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
14.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
14.5.1.1. Hospitals & Clinics
14.5.1.2. Private Commercial Laboratories
14.5.1.3. Government/ Publicly Funded Programs
14.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
14.5.3. Pricing Analysis
14.5.4. Government Initiatives and Spending Scenario
14.6. Columbia Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
14.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
14.6.1.1. Hospitals & Clinics
14.6.1.2. Private Commercial Laboratories
14.6.1.3. Government/ Publicly Funded Programs
14.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
14.6.3. Pricing Analysis
14.6.4. Government Initiatives and Spending Scenario
14.7. Market Attractiveness Analysis
14.7.1. By Country
14.7.2. By End User
14.8. Key Market Participants – Intensity Mapping
15. Central America Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
15.1. Introduction
15.2. Key Takeaways
15.3. Regional Market Trends
15.4. Central America Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
15.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
15.4.1.1. Hospitals & Clinics
15.4.1.2. Private Commercial Laboratories
15.4.1.3. Government/ Publicly Funded Programs
15.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
15.4.3. Pricing Analysis
15.4.4. Government Initiatives and Spending Scenario
15.5. Key Competition Mapping
15.6. Market Attractiveness Analysis
15.6.1. By End User
15.7. Key Market Participants – Intensity Mapping
16. South-East Asia Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
16.1. Introduction
16.2. Key Takeaways
16.3. Regional Market Trends
16.4. Indonesia Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
16.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
16.4.1.1. Hospitals & Clinics
16.4.1.2. Private Commercial Laboratories
16.4.1.3. Government/ Publicly Funded Programs
16.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
16.4.3. Pricing Analysis
16.4.4. Government Initiatives and Spending Scenario
16.5. Thailand Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
16.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
16.5.1.1. Hospitals & Clinics
16.5.1.2. Private Commercial Laboratories
16.5.1.3. Government/ Publicly Funded Programs
16.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
16.5.3. Pricing Analysis
16.5.4. Government Initiatives and Spending Scenario
16.6. Singapore Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
16.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
16.6.1.1. Hospitals & Clinics
16.6.1.2. Private Commercial Laboratories
16.6.1.3. Government/ Publicly Funded Programs
16.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
16.6.3. Pricing Analysis
13.6.4. Government Initiatives and Spending Scenario
16.7. Vietnam Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
16.7.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
16.7.1.1. Hospitals & Clinics
16.7.1.2. Private Commercial Laboratories
16.7.1.3. Government/ Publicly Funded Programs
16.7.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
16.7.3. Pricing Analysis
16.7.4. Government Initiatives and Spending Scenario
16.8. Key Competition Mapping
16.9. Market Attractiveness Analysis
16.9.1. By Country
16.9.2. By End User
16.10. Key Market Participants – Intensity Mapping
17. Rest of the World Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
17.1. Introduction
17.2. Key Takeaways
17.3. Regional Market Trends
17.4. North Africa Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
17.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
17.4.1.1. Hospitals & Clinics
17.4.1.2. Private Commercial Laboratories
17.4.1.3. Government/ Publicly Funded Programs
17.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
17.4.3. Pricing Analysis
17.4.4. Government Initiatives and Spending Scenario
17.5. South Africa Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031
17.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020
17.5.1.1. Hospitals & Clinics
17.5.1.2. Private Commercial Laboratories
17.5.1.3. Government/ Publicly Funded Programs
17.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031
17.5.3. Pricing Analysis
17.5.4. Government Initiatives and Spending Scenario
17.6. Key Competition Mapping
17.7. Market Attractiveness Analysis
17.7.1. By Country
17.7.2. By End User
17.8. Key Market Participants – Intensity Mapping
18. Forecast Factors: Relevance and Impact
19. Forecast Assumptions
20. Market Structure Analysis
20.1. Market Structure by Tier of Companies
20.2. Market Share Analysis (2016) for Top 10 Players, By Region
20.3. Production Capacity Analysis, By Key Players
20.4. Pricing Analysis By Key Players, By Region
21. Competition Analysis
21.1. Company Deep Dive Profile of some of the key market players, with specific focus on business and Zika Virus Testing Market
21.2. Competition Dashboard
21.3. Competition Benchmarking
21.4. Profitability and Gross Margin Analysis By Competition
21.5. Company Deep Dive
21.5.1. EUROIMMUN US, Inc.
21.5.1.1. Overview
21.5.1.2. Product and Application Portfolio
21.5.1.3. Production Footprint
21.5.1.4. Sales Footprint
21.5.1.5. Channel Footprint
21.5.1.6. Strategy
21.5.1.6.1. Marketing Strategy
21.5.1.6.2. Product Strategy
21.5.1.6.3. Channel Strategy
21.5.2. Creative Diagnostics
21.5.2.1. Overview
21.5.2.2. Product and Application Portfolio
21.5.2.3. Production Footprint
21.5.2.4. Sales Footprint
21.5.2.5. Channel Footprint
21.5.2.6. Strategy
21.5.2.6.1. Marketing Strategy
21.5.2.6.2. Product Strategy
21.5.2.6.3. Channel Strategy
21.5.3. Quest Diagnostics
21.5.3.1. Overview
21.5.3.2. Product and Application Portfolio
21.5.3.3. Production Footprint
21.5.3.4. Sales Footprint
21.5.3.5. Channel Footprint
21.5.3.6. Strategy
21.5.3.6.1. Marketing Strategy
21.5.3.6.2. Product Strategy
21.5.3.6.3. Channel Strategy
21.5.4. Artron Laboratories Inc.
21.5.4.1. Overview
21.5.4.2. Product and Application Portfolio
21.5.4.3. Production Footprint
21.5.4.4. Sales Footprint
21.5.4.5. Channel Footprint
21.5.4.6. Strategy
21.5.4.6.1. Marketing Strategy
21.5.4.6.2. Product Strategy
21.5.4.6.3. Channel Strategy
21.5.5. RapiGEN Inc.
21.5.5.1. Overview
21.5.5.2. Product and Application Portfolio
21.5.5.3. Production Footprint
21.5.5.4. Sales Footprint
21.5.5.5. Channel Footprint
21.5.5.6. Strategy
21.5.5.6.1. Marketing Strategy
21.5.5.6.2. Product Strategy
21.5.5.6.3. Channel Strategy
21.5.6. GenBody Inc.
21.5.6.1. Overview
21.5.6.2. Product and Application Portfolio
21.5.6.3. Production Footprint
21.5.6.4. Sales Footprint
21.5.6.5. Channel Footprint
21.5.6.6. Strategy
21.5.6.6.1. Marketing Strategy
21.5.6.6.2. Product Strategy
21.5.6.6.3. Channel Strategy
21.5.7. JAJ International, Inc.
21.5.7.1. Overview
21.5.7.2. Product and Application Portfolio
21.5.7.3. Production Footprint
21.5.7.4. Sales Footprint
21.5.7.5. Channel Footprint
21.5.7.6. Strategy
21.5.7.6.1. Marketing Strategy
21.5.7.6.2. Product Strategy
21.5.7.6.3. Channel Strategy
21.5.8. LumiQuick Diagnostics, Inc.
21.5.8.1. Overview
21.5.8.2. Product and Application Portfolio
21.5.8.3. Production Footprint
21.5.8.4. Sales Footprint
21.5.8.5. Channel Footprint
21.5.8.6. Strategy
21.5.8.6.1. Marketing Strategy
21.5.8.6.2. Product Strategy
21.5.8.6.3. Channel Strategy
21.5.9. Biocan Diagnostics Inc.
21.5.9.1. Overview
21.5.9.2. Product and Application Portfolio
21.5.9.3. Production Footprint
21.5.9.4. Sales Footprint
21.5.9.5. Channel Footprint
21.5.9.6. Strategy
21.5.9.6.1. Marketing Strategy
21.5.9.6.2. Product Strategy
21.5.9.6.3. Channel Strategy
21.5.10. NECTAR LIFESCIENCES LTD.
21.5.10.1. Overview
21.5.10.2. Product and Application Portfolio
21.5.10.3. Production Footprint
21.5.10.4. Sales Footprint
21.5.10.5. Channel Footprint
21.5.10.6. Strategy
21.5.10.6.1. Marketing Strategy
21.5.10.6.2. Product Strategy
21.5.10.6.3. Channel Strategy
22. Assumptions and Acronyms Used
22.1. A glossary of assumption and acronyms used in the report
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Zika Virus Testing Market Pricing Analysis (US$) By Region, 2021
Table 02: North America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country
Table 03: North America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type
Table 04: North America Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type
Table 05: North America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User
Table 06: Latin America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country
Table 07: Latin America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type
Table 08: Latin America Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type
Table 09: Latin America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User
Table 10: Europe Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country
Table 11: Europe Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type
Table 12: Europe Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type
Table 13: Europe Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User
Table 14: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country
Table 15: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type
Table 16: Central America Cluster Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type
Table 17: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User
Table 18: South-East Asia Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country
Table 19: South-East Asia Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type
Table 20: South-East Asia Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type
Table 21: South-East Asia Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User
Table 22: Caribbean Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type
Table 23: Caribbean Cluster Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type
Table 24: Caribbean Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User
Table 25: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country
Table 26: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type
Table 27: Central America Cluster Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type
Table 28: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User
Table 29: Global Zika Virus Testing Market Size (US$ Mn) 2016-2020 And Forecast 2021-2031 By Region
Table 30: Global Zika Virus Testing Market Size (US$ Mn) 2016-2020 And Forecast 2021-2031 By Test Type
Table 31: Global Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type
Table 32: Global Zika Virus Testing Market Size (US$ Mn) 2016-2020 And Forecast 2021-2031 By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Zika Virus Testing Market Revenue Share By Test Type 2021E & 2031F
Figure 02: Zika Virus Testing Market Revenue Share By End User, 2021E & 2031F
Figure 03: Zika Virus Testing Market Revenue Share By Region, 2021E & 2031F
Figure 04: Global Zika Virus Testing Market Absolute $ Opportunity (US$ Mn), 2020 – 2031
Figure 05: Zika Virus Testing Market, Price (US$) Difference (U.S Vs. Caribbean Cluster), 2016
Figure 06: Global Zika Virus Testing Market Brush Motors, Price Difference (US$) By Region, 2021
Figure 07: Global Zika Virus Testing Market Brush Motors, Price Difference (US$) By Region, 2031
Figure 08: Global Zika Virus Testing Market Brushless Motors, Price Difference (US$) By Region, 2021
Figure 09: Global Zika Virus Testing Market Brushless Motors, Price Difference (US$) By Region, 2031
Figure 10: North America Zika Virus Testing Market Value Share (2021E)
Figure 11: North America Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031
Figure 12: North America Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020
Figure 13: North America Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 14: U.S. Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 15: U.S. Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 16: Canada Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 17: Canada Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 18: North America Brush Motors Market Size (US$ Mn) Analysis, 2016-2020
Figure 19: North America Brush Motors Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 20: North America Brushless Motors Market Size (US$ Mn) Analysis, 2016-2020
Figure 21: North America Brushless Motors Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 22: North America Dental Clinics Market Size (US$ Mn) Analysis, 2016-2020
Figure 23: North America Dental Clinics Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 24: North America Hospitals Market Size (US$ Mn) Analysis, 2016-2020
Figure 25: North America Hospitals Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 26: North America Others Market Size (US$ Mn) Analysis, 2016-2020
Figure 27: North America Others Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 28: North America Zika Virus Testing Market Attractiveness Analysis By Test Type, 2021-2031
Figure 29: North America Zika Virus Testing Market Attractiveness Analysis By End User, 2021-2031
Figure 30: North America Zika Virus Testing Market Attractiveness Analysis By Country, 2021-2031
Figure 31: Latin America Zika Virus Testing Market Value Share (2021E)
Figure 32: Latin America Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031
Figure 33: Latin America Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020
Figure 34: Latin America Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 35: Brazil Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 36: Brazil Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 37: Mexico Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 38: Mexico Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 39: Rest Of Latin America Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 40: Rest Of Latin America Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 41: Latin America Brush Motors Market Size (US$ Mn) Analysis, 2016-2020
Figure 42: Latin America Brush Motors Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 43: Latin America Brushless Motors Market Size (US$ Mn) Analysis, 2016-2020
Figure 44: Latin America Brushless Motors Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 45: Latin America Dental Clinics Market Size (US$ Mn) Analysis, 2016-2020
Figure 46: Latin America Dental Clinics Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 47: Latin America Hospitals Market Size (US$ Mn) Analysis, 2016-2020
Figure 48: Latin America Hospitals Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 49: Latin America Others Market Size (US$ Mn) Analysis, 2016-2020
Figure 50: Latin America Others Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 51: Latin America Zika Virus Testing Market Attractiveness Analysis By Test Type, 2021-2031
Figure 52: Latin America Zika Virus Testing Market Attractiveness Analysis By End User, 2021-2031
Figure 53: Latin America Zika Virus Testing Market Attractiveness Analysis By Country, 2021-2031
Figure 54: Europe Zika Virus Testing Market Value Share (2021E)
Figure 55: Europe Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031
Figure 56: Europe Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020
Figure 57: Europe Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 58: U.K. Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 59: U.K. Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 60: Germany Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 61: Germany Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 62: France Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 63: France Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 64: Italy Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 65: Italy Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 66: Spain Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 67: Spain Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 68: Nordic Countries Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 69: Nordic Countries Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 70: Central America Cluster Zika Virus Testing Market Value Share (2021E)
Figure 71: Central America Cluster Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031
Figure 72: Central America Cluster Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020
Figure 73: Central America Cluster Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 74: Costa Rica Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 75: Costa Rica Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 76: Nicaragua Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 77: Nicaragua Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 78: Rest Of Central America Cluster Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 79: Rest Of Central America Cluster Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 80: Central America Cluster Zika Virus Testing Market Attractiveness Analysis By Test Type, 2021-2031
Figure 81: Central America Cluster Zika Virus Testing Market Attractiveness Analysis By End User, 2021-2031
Figure 82: South-East Asia Zika Virus Testing Market Value Share (2021E)
Figure 83: South-East Asia Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031
Figure 84: South-East Asia Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020
Figure 85: South-East Asia Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 86: Singapore Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 87: Singapore Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 88: Thailand Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 89: Thailand Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 90: Vietnam Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 91: Vietnam Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 92: Rest Of South-East Asia Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020
Figure 93: Caribbean Cluster Zika Virus Testing Market Value Share Analysis (%) By End User, 2021 & 2031
Figure 94: Caribbean Cluster Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020
Figure 95: Caribbean Cluster Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031
Figure 96: Central America Cluster Zika Virus Testing Market Value Share (2021E)
Figure 97: Central America Cluster Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031
Figure 98: Global Zika Virus Testing Market Share Analysis (%) By Region, 2021 & 2031
Figure 99: Global Zika Virus Testing Market Y-O-Y Growth (%) 2021-2031, By Region
Figure 100: Global Zika Virus Testing Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 101: Global Zika Virus Testing Market Y-O-Y Growth (%) 2021-2031, By Test Type
Figure 102: Global Zika Virus Testing Market Attractiveness Analysis By Test Type, 2021-2031
Figure 103: Global Zika Virus Testing Market Share Analysis (%) By End User, 2021 & 2031
Figure 104: Global Zika Virus Testing Market Y-O-Y Growth (%) 2021-2031, By End User
Figure 105: Global Zika Virus Testing Market Attractiveness Analysis By End User, 2021-2031
Figure 106: Global Zika Virus Testing Market Value Analysis And Forecast, 2016–2031 (US$ Mn)
Figure 107: Global Zika Virus Testing Market Absolute $ Opportunity (US$ Mn), 2016-2020
Figure 108: Global Zika Virus Testing Market Absolute $ Opportunity (US$ Mn), 2016–2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports